©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 109375
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.109375
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.109375
Table 1 Baseline characteristics of participants, n (%)
| Parameters | Sevoflurane group (n = 103) | Propofol group (n = 101) | t/χ2 | P value |
| Age (years) | 59.72 ± 9.79 | 60.21 ± 10.13 | 0.349 | 0.728 |
| Sex | 0.245 | 0.621 | ||
| Male | 67 (65.05) | 69 (68.32) | ||
| Female | 36 (34.95) | 32 (31.68) | ||
| BMI (kg/m2) | 23.79 ± 2.25 | 24.10 ± 2.53 | 0.910 | 0.364 |
| ECOG | 0.003 | 0.954 | ||
| 0 | 88 (85.44) | 86 (85.15) | ||
| 1 | 15 (14.56) | 15 (14.85) | ||
| ASA classification | 0.420 | 0.811 | ||
| I | 44 (42.72) | 41 (40.59) | ||
| II | 58 (56.31) | 58 (57.43) | ||
| III | 1 (0.97) | 2 (1.98) | ||
| Systolic blood pressure (mmHg) | 115.01 ± 11.62 | 114.09 ± 11.28 | 0.572 | 0.568 |
| Diastolic blood pressure (mmHg) | 75.33 ± 10.12 | 72.70 ± 11.01 | 1.778 | 0.077 |
| Heart rate (bpm) | 129.78 ± 24.25 | 135.41 ± 25.30 | 1.622 | 0.106 |
| Hemoglobin (g/dL) | 12.98 ± 1.28 | 13.10 ± 1.33 | 0.659 | 0.510 |
| Underlying diseases | ||||
| Hypertension | 79 (76.70) | 71 (70.30) | 1.074 | 0.300 |
| Diabetes | 37 (35.92) | 46 (54.46) | 1.956 | 0.162 |
- Citation: Wang Z, Cheng JW, Yu KY. Short-term and long-term effects of sevoflurane inhalation vs propofol total intravenous anesthesia in gastrectomy for gastric cancer. World J Gastrointest Oncol 2025; 17(11): 109375
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/109375.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.109375